JINYU(600201)2024-10-30 10:15Revenue and Profit - Revenue for Q3 2024 was CNY 359,073,392.22, a decrease of 32.79% year-over-year[2] - Net profit attributable to shareholders for Q3 2024 was CNY 46,622,327.14, down 69.70% compared to the same period last year[2] - Basic earnings per share for Q3 2024 was CNY 0.04, a decline of 71.43% year-over-year[3] - The company reported a decrease in net profit attributable to shareholders for the year-to-date period of 41.19%[7] - Total operating revenue for the first three quarters of 2024 was CNY 970,804,600.73, a decrease of 20.3% compared to CNY 1,218,989,228.41 in the same period of 2023[16] - Net profit for the third quarter of 2024 was CNY 170,256,021.00, down 40.4% from CNY 285,758,448.43 in the same quarter of 2023[18] - The net profit attributable to the parent company shareholders for the third quarter was approximately ¥169.54 million, a decrease from ¥288.31 million in the same period last year, representing a decline of about 41.2%[19] - The total comprehensive income attributable to the parent company owners was approximately ¥161.84 million, down from ¥288.47 million year-over-year, indicating a decrease of around 43.8%[19] - The basic and diluted earnings per share for the third quarter were both ¥0.15, compared to ¥0.26 in the previous year, reflecting a decline of approximately 42.3%[19] Cash Flow - The net cash flow from operating activities for the year-to-date period was CNY 211,278,277.27, down 28.49% year-over-year[2] - Cash inflows from operating activities totaled approximately ¥1.01 billion, down from ¥1.26 billion in the same period last year, representing a decrease of about 19.6%[21] - The net cash flow from operating activities was approximately ¥211.28 million, compared to ¥295.45 million in the same period last year, a decrease of around 28.5%[21] - The net cash flow from investing activities was negative at approximately -¥297.66 million, compared to -¥237.24 million in the previous year, indicating a worsening of about 25.5%[22] - The net cash flow from financing activities was negative at approximately -¥96.82 million, contrasting with a positive cash flow of ¥111.84 million in the same period last year[22] - The total cash and cash equivalents at the end of the period were approximately ¥869.58 million, down from ¥1.44 billion at the end of the previous year, reflecting a decrease of about 39.6%[22] Assets and Liabilities - Total assets as of the end of Q3 2024 were CNY 6,903,124,320.81, representing a slight increase of 0.44% from the end of the previous year[3] - As of September 30, 2024, the company's total current assets amounted to approximately CNY 2.45 billion, a decrease of 18.8% from CNY 3.02 billion on December 31, 2023[13] - The company's cash and cash equivalents decreased from CNY 1.71 billion at the end of 2023 to CNY 1.28 billion, reflecting a decline of 25.3%[13] - Accounts receivable decreased from CNY 857.49 million to CNY 745.12 million, a reduction of 13.1%[13] - Inventory decreased from CNY 322.25 million to CNY 283.08 million, a decline of 12.2%[13] - The company's long-term equity investments slightly decreased from CNY 266.28 million to CNY 263.27 million, a decrease of 1.1%[13] - The total non-current assets increased from CNY 2.56 billion to CNY 2.58 billion, reflecting a growth of 0.8%[13] - The company's fixed assets increased from CNY 1.52 billion to CNY 1.63 billion, an increase of 5.4%[13] - Total liabilities increased to CNY 1,353,964,961.43 from CNY 1,217,642,217.42, representing a rise of 11.2%[15] Expenses - Total operating costs decreased to CNY 775,774,038.75 from CNY 896,303,403.85, reflecting a reduction of 13.5%[16] - Research and development expenses for the third quarter of 2024 were CNY 88,026,265.74, compared to CNY 109,253,292.83 in the same quarter of 2023, indicating a decrease of 19.4%[18] - The company reported a decrease in sales expenses to CNY 194,238,768.85 from CNY 226,879,602.40, a reduction of 14.4%[18] Shareholder Information - The largest shareholder, Inner Mongolia Jinyu Biological Holdings Co., Ltd., holds 10.92% of the shares, with 23,780,000 shares pledged[8] - The company has not reported any significant changes in shareholder participation in margin trading and securities lending activities[11] Other Information - The company experienced a significant decline in revenue due to intensified industry competition and changes in product sales structure[6] - Non-recurring gains for Q3 2024 amounted to CNY 7,922,872.21, with a year-to-date total of CNY 22,977,722.67[5] - The company's weighted average return on equity decreased by 2.08 percentage points to 0.86% for Q3 2024[3] - There are no other important reminders regarding the company's operational situation during the reporting period[13] - The company has not adopted new accounting standards or interpretations that would affect the financial statements for the current year[23]